SCHEMBL29636115

SCHEMBL29636115

CCOc1ccc(F)cc1-c1cnc2[nH]c(=O)[nH]c2c1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRIN1 Q05586 14/20 0.56
GRIN2B Q13224 14/20 0.56
PRKD3 O94806 2/20 0.49
MAP4K4 O95819 2/20 0.49
RET P07949 2/20 0.49
PIM1 P11309 2/20 0.49
KDR P35968 2/20 0.49
GSK3A P49840 2/20 0.49
GSK3B P49841 2/20 0.49
RPS6KA3 P51812 2/20 0.49
CDK5 Q00535 2/20 0.49
MAP4K2 Q12851 2/20 0.49
AURKB Q96GD4 2/20 0.49
CLK4 Q9HAZ1 2/20 0.49
PLK4 O00444 1/20 0.49
CHEK1 O14757 1/20 0.49
CDK1 P06493 1/20 0.49
LYN P07948 1/20 0.49
FER P16591 1/20 0.49
CDK2 P24941 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29636099 0.88 RET (0.58) GRIN1GRIN2BPRKD3MAP4K4RET
SCHEMBL29636006 0.80 GRIN1 (0.56) GRIN1GRIN2BPRKD3MAP4K4RET
SCHEMBL29635977 0.78 PRKD3 (0.55) GRIN1GRIN2BPRKD3MAP4K4RET
SCHEMBL25589851 0.74 GRIN1 (0.72) GRIN1GRIN2B
SCHEMBL29636054 0.73 PRKD3 (0.63) GRIN1GRIN2BPRKD3MAP4K4RET
SCHEMBL20773071 0.73 PLK4 (0.59) GRIN1GRIN2BPRKD3MAP4K4RET
SCHEMBL16990432 0.72 TDO2 (0.56) PRKD3MAP4K4RETPIM1KDR
SCHEMBL30176750 0.72 PRKD3 (0.55) GRIN1GRIN2BPRKD3MAP4K4RET
SCHEMBL20134073 0.72 GRIN1 (1.00) GRIN1GRIN2B
SCHEMBL20134083 0.72 GRIN1 (1.00) GRIN1GRIN2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230338341-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-10-26 US disclosed
US-11759455-B2 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators JANSSEN PHARMACEUTICA NV (BE) 2023-09-19 US disclosed
US-20230000833-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2023-01-05 US disclosed
CN-114989164-A Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-09-02 CN disclosed
CN-110062761-B Substituted 1H-imidazo [4,5-b ] pyridin-2 (3H) -ones and uses thereof 詹森药业有限公司 2022-05-13 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230000833-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS GRIN2B, GRIN2A, GRIN2C GRIN1 6/4885GRIN2B 1/4885PRKD3 2794/4885
US-11759455-B2 Substituted 1H-imidazo[4,5-b]pyridin-2(3H)-ones and their use as GLUN2B receptor modulators GRIN2B, GRIN2A, GRIN2C GRIN1 6/4885GRIN2B 1/4885PRKD3 2794/4885
US-20230338341-A1 SUBSTITUTED 1H-IMIDAZO[4,5-b]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS GRIN2B, GRIN2A, GRIN2C GRIN1 6/4885GRIN2B 1/4885PRKD3 2794/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.